Factor Xa inhibitors (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFactor Xa inhibitors (AstraZeneca)
Drug Alias Nameantithrombotic (AstraZeneca)Factor Xa inhibitors (Zeneca)antithrombotic (Zeneca)AZ-11757790AZ-12300547 +[8] 
ClassificationSmall molecules
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeneca Group PlcAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A